Mostrando 2 resultados de: 2
Current perspectives on interethnic variability in multiple myeloma: Single cell technology, population pharmacogenetics and molecular signal transduction
ArticleAbstract: Multiple myeloma (MM) is an aggressive cancer characterised by malignancy of the plasma cells and aPalabras claves:Cáncer, Drug resistance, Interethnic variability, Molecular aspects, Multiple myeloma, population pharmacogenetics, Precision Medicine, signal transductionAutores:Adrián LLerena, Bakhai V., de Andrés F., Gandhi M., Mishra A., Nair S., Sharma R., Trivedi J.Fuentes:scopusPbkp_redictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
ReviewAbstract: Bevacizumab was the first molecular-targeted antiangiogenic therapy approved for the treatment of mePalabras claves:Bevacizumab, Biomarker, Cáncer, colorectalAutores:Adrián LLerena, Alonso I., Arroyo G., de Andrés F., Estévez-Carrizo F.E., González-Vacarezza N., Martínez J.Fuentes:scopus